The Diabetic Urologic Disease program encompasses basic, translational, and clinical studies to advance our knowledge on how diabetes affects the function of the bladder, prostate, lower urinary tract and male sexual organs.
This program supports a range of studies utilizing mammalian and non-mammalian model systems to interrogate the molecular mechanisms of diabetic uropathy, as well as studies using human tissue. Clinical investigations focusing on novel interventions to alleviate urologic sequelae of diabetes are also encouraged. Of particular interest are studies focused on the intersection between steroid hormone signaling and mechanisms of diabetic-induced prostate growth and male sexual function. Clinical and epidemiologic investigations focused on diabetic uropathy and leveraging existing diabetic cohorts are also encouraged.